NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guérin therapy for bladder cancer

European Urology

Volumn 59, Issue 3, 2011, Pages 430-437

  Chiong, Edmund ^a,b   Kesavan, Arshvin ^a   Mahendran, Ratha ^b   Chan, Yiong Huak ^c   Sng, Jen Hwei ^b   Lim, Yew Koon ^b   Kamaraj, Revathi ^a   Tan, Theresa M C ^b   Esuvaranathan, Kesavan ^a,b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bacillus Calmette Gu rin; Bladder cancer; Gene polymorphism

Indexed keywords

ALPHA2B INTERFERON; ASPARAGINE; ASPARTIC ACID; BCG VACCINE; GLUTATHIONE PEROXIDASE 1; HUMAN GLUTATHIONE PEROXIDASE 1; LEUCINE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; PROLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BCG VACCINATION; BLADDER BIOPSY; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; DNA DETERMINATION; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE;

ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CATION TRANSPORT PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE PEROXIDASE; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROMOTER REGIONS, GENETIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 79551473161     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.11.031     Document Type: Article

References (30)

1. P. Gontero, A. Bohle, and P.-U. Malmstrom The role of bacillus Calmette-Guérin in the treatment of non-muscle-invasive bladder cancer Eur Urol 57 2010 410 429
2. R.J. Sylvester, A.P.M. van der Meijden, and D.L. Lamm Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
3. M. Franekova, E. Halasova, E. Bukovska, J. Luptak, and D. Dobrota Gene polymorphisms in bladder cancer Urol Oncol 26 2008 1 8
4. R.S. Weinstein, J.S. Coon, D. Schwartz, A.W. Miller 3rd, and B.U. Pauli Pathology of superficial bladder cancer with emphasis on carcinoma in situ Urology 26 1985 2 10
5. C. Kwak, J.H. Ku, J.Y. Park, E. Lee, S.E. Lee, and C. Lee Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer J Urol 171 2004 149 152
6. D.K. Ahirwar, A. Agrahari, A. Mandhani, and R.D. Mittal Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy Biomarkers 14 2009 213 218
7. D.K. Ahirwar, A. Mandhani, A. Dharaskar, P. Kesarwani, and R.D. Mittal Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy BJU Int 104 2009 867 873
8. M. Decobert, H. Larue, and A. Bergeron Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer J Urol 175 2006 1506 1511
9. H. Zhao, D. Liang, H.B. Grossman, and X. Wu Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer Urology 66 2005 769 774
10. P. Gros, E. Skamene, and A. Forget Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice J Immunol 127 1981 2417 2421
11. N. Buu, F. Sanchez, and E. Schurr The Bcg host-resistance gene Clin Infect Dis 31 Suppl 3 2000 S81 S85
12. M. Potter, A.D. O'Brien, and E. Skamene A BALB/c congenic strain of mice that carries a genetic locus (Ityr) controlling resistance to intracellular parasites Infect Immun 40 1983 1234 1235
13. E. Skamene, P. Gros, A. Forget, P.A. Kongshavn, C. St Charles, and B.A. Taylor Genetic regulation of resistance to intracellular pathogens Nature 297 1982 506 509
14. S.A. Kadhim, J.L. Chin, E. Batislam, S.J. Karlik, B. Garcia, and E. Skamene Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor J Urol 158 1997 646 652
15. R. Bellamy, C. Ruwende, T. Corrah, K.P. McAdam, H.C. Whittle, and A.V. Hill Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans N Engl J Med 338 1998 640 644
16. K.H. Leung, S.P. Yip, and W.S. Wong Sex- and age-dependent association of SLC11A1 polymorphisms with tuberculosis in Chinese: a case control study BMC Infect Dis 7 2007 19
17. X. Ma, S. Dou, and J.A. Wright 5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas Int J Tuberc Lung Dis 6 2002 818 823
18. P.S. Gao, S. Fujishima, and X.Q. Mao Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team Clin Genet 58 2000 74 76
19. S. Ryu, Y.K. Park, G.H. Bai, S.J. Kim, S.N. Park, and S. Kang 3'UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans Int J Tuberc Lung Dis 4 2000 577 580
20. Y. Ichimura, T. Habuchi, and N. Tsuchiya Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant J Urol 172 2004 728 732
21. R.J. Sylvester, A.P.M. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 477 discussion 475-7
22. J. Liu, T.M. Fujiwara, and N.T. Buu Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene Am J Hum Genet 56 1995 845 853
23. S. Gruenheid, E. Pinner, M. Desjardins, and P. Gros Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome J Exp Med 185 1997 717 730
24. J.R. Boelaert, S.J. Vandecasteele, R. Appelberg, and V.R. Gordeuk The effect of the host's iron status on tuberculosis J Infect Dis 195 2007 1745 1753
25. E.G. Hoal, L.A. Lewis, and S.E. Jamieson SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa Int J Tuberc Lung Dis 8 2004 1464 1471
26. Y. Zhang, Y. Ikeno, and W. Qi Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity J Gerontol A Biol Sci Med Sci 64 2009 1212 1220
27. N. Badjatia, A. Satyam, P. Singh, A. Seth, and A. Sharma Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma Urol Oncol 28 2010 360 367
28. Y.J. Hu, and A.M. Diamond Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium Cancer Res 63 2003 3347 3351
29. J. Nordberg, and E.S. Arner Reactive oxygen species, antioxidants, and the mammalian thioredoxin system Free Radic Biol Med 31 2001 1287 1312
30. S.H. Pook, K. Esuvaranathan, and R. Mahendran N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized Mycobacterium bovis in human bladder cancer cells J Urol 168 2002 780 785